Patents by Inventor Alejandro Balazs

Alejandro Balazs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Populations of hematopoietic stem cells
    Patent number: 8586100
    Abstract: Described herein are methods for purifying hematopoietic stem cells. Also described herein are methods for purifying EPCR+ cells. The invention also provides substantially pure isolated hematopoietic stems cells, including EPCR+ hematopoietic stem cells.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: November 19, 2013
    Assignee: Children's Medical Center Corporation
    Inventors: Alejandro Balazs, Richard Mulligan
  • METHODS FOR PURIFYING HEMATOPOIETIC STEM CELLS
    Publication number: 20120121552
    Abstract: Described herein are methods for purifying hematopoietic stem cells. Also described herein are methods for purifying EPCR+ cells. The invention also provides substantially pure isolated hematopoietic stems cells, including EPCR+ hematopoietic stem cells.
    Type: Application
    Filed: November 17, 2011
    Publication date: May 17, 2012
    Applicant: Children's Medical Center Corporation
    Inventors: Alejandro Balazs, Richard Mulligan
  • Methods for purifying hematopoietic stem cells
    Patent number: 8088585
    Abstract: Described herein are methods for purifying hematopoietic stem cells. Also described herein are methods for purifying EPCR+ cells. The invention also provides substantially pure isolated hematopoietic stems cells, including EPCR+ hematopoietic stem cells.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: January 3, 2012
    Assignee: Children's Medical Center Corporation
    Inventors: Alejandro Balazs, Richard Mulligan
  • Methods for purifying hematopoietic stem cells
    Publication number: 20070134208
    Abstract: Described herein are methods for purifying hematopoietic stem cells. Also described herein are methods for purifying EPCR+ cells. The invention also provides substantially pure isolated hematopoietic stems cells, including EPCR+ hematopoietic stem cells.
    Type: Application
    Filed: October 29, 2004
    Publication date: June 14, 2007
    Applicant: Children's Medical Center Corporation
    Inventors: Alejandro Balazs, Richard Mulligan